Biography

Dr. Kevin Albuquerque earned his medical degree through Bombay University, India. This was followed by a residency and training in surgical oncology in Bombay and Nottingham U.K where he obtained his F.R.C.S. In the U.S.,  he completed his residency in Radiation Oncology at S.U.N.Y University Hospital in Brooklyn, NY and was board-certified in 2002. 

Subsequently from 2002-2012, he was on faculty with Loyola University Medical Center, Chicago, where he treated women with gynecological and breast cancers and was Clinical Director and Section Chief in Radiation Oncology for these sites. Besides being awarded a Loyola Cancer Center grant for research comparing breast brachytherapy with external radiotherapy, he was in collaboration on several funded NIH grants looking at translational effects of breast radiation on immune markers, psychoneuroimmunology in breast cancer patients, and decision-making for women with DCIS undergoing breast-conservation therapy. He also obtained a master’s degree in clinical research methods at Loyola.

Dr. Albuquerque heads our Department of Radiation Oncology gynecology team and continues research in brachytherapy and gynecological and breast tumors. His main area of interest are epidemiology, quality-of-life issues, and outcome studies and clinical trials incorporating radiation for gynecological cancers.

Education

Medical School
Lokmanya Tilak Municipal Medical College, India (1984)
Internship
Maimonides Medical Center (1998), General Surgery
Residency
State University of New York at Brooklyn (2002), Radiation Oncology
Other Post Graduate Training
Loyola University Chicago Stritch School of Medicine (2007), Epidemiology

Research Interest

  • Bone marrow-sparing techniques for pelvic radiation
  • Brachytherapy outcomes for gynecological cancers
  • SABR for gynecological cancers, in combination with immunotherapy

Publications

Featured Publications LegendFeatured Publications

Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancer.
Albuquerque KV, Singla R, Potkul RK, Smith DM, Creech S, Lo S, Emami B Gynecol. Oncol. 2005 Mar 96 3 701-4
Synergistic anti-proliferative activity of interleukin 1 and tumor necrosis factor.
Ruggiero V, Baglioni C J. Immunol. 1987 Feb 138 3 661-3

Books

Featured Books Legend Featured Books

Professional Associations/Affiliations

  • ASCO Annual Meeting Scientific Program Committee (2019)
  • Chinese Clinical Oncology Journal (2019)
  • Parkland Cancer Committee Member (2019)
  • NRG RT Translational Committee (2018)
  • Red Journal for Gynecology (2018)
  • ASTRO MDQA Committee (2017)
  • American Society of Clinical Oncology (ASCO) (2011)
  • American Brachytherapy Society (2004-2006)
  • American Brachytherapy Society (ABS) (1998)
  • American College of Radiology (ACR) (1998)
  • American Society of Therapeutic Radiology (ASTRO) (1998)
  • Radiological Society of North America (RSNA) (1998)